Adaptimmune Therapeutics Plc (ADAPY)
0.0525
0.00 (0.00%)
USD |
OTCM |
Dec 09, 16:00
Adaptimmune Therapeutics Total Liabilities (Quarterly): 201.59M for June 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 8.601M |
| Autolus Therapeutics Plc | 396.50M |
| Mereo BioPharma Group Plc | 7.004M |
| Bicycle Therapeutics Plc | 145.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 130.63M |
| Shareholders Equity (Quarterly) | -70.96M |
| Debt to Equity Ratio | -0.686 |
| Current Ratio | 1.516 |
| Net Debt Paydown Yield | -7.87% |